Skip to content

T2 Weighted Imaging of the Liver With Fast Spin Echo MRI

Enhancement of T2 Weighted Imaging of the Liver With Fast Spin Echo Magnetic Resonance Imaging (MRI).

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02186054
Enrollment
50
Registered
2014-07-10
Start date
2014-06-30
Completion date
2016-06-30
Last updated
2015-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Disease

Keywords

Abdominal-Pelvic MRI (magnetic resonance image), T2W (T2 weighted), FSE Flex (recently developed MRI pulse sequence), Enhanced single shot FSE (fast spin echo).

Brief summary

The purpose of this study is to test two new MRI (magnetic resonance imaging) sequences to see how they compare to previously used imaging sequences as they may improve the quality of abdominal MRI.

Detailed description

* Approximately 50 patients undergoing routine liver MRI in our practice imaged with one of our 4 clinical scanners will undergo our standard liver MRI protocol with the addition of 2 breath-hold sequences (FSE Flex and eSSFSE) only increasing the scan time by approximately 3 minutes. * Data will be retrieved from examinations that have been performed from the patient's electronic imaging file stored in our picture archiving and communication system (PACS). * Images will be completely anonymized. No patient identifiers will be available on the images during the analysis. * Analyses will include the visual assessment of image quality, presence and severity of imaging artifact and other non-invasive imaging outcomes performed by radiologists blinded to patient information and the type of sequence performed. Data will be presented in a Likert type scale (1=poor, 2=suboptimal, 3=average, 4=above average and 5=excellent) and imaging parameters will be compared using the Wilcoxon sign rank test.

Interventions

Consented patients will be required to stay in the MRI scanner to complete the 2 additional sequences once their standard exam is completed.

Sponsors

Ottawa Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients undergoing routine liver MRI imaged with one of our 4 clinical scanners (MR 750W, General Electric, Milwaukee WI)

Exclusion criteria

* Patients not undergoing routine liver MRI

Design outcomes

Primary

MeasureTime frameDescription
The number of abdominal MRI scans deemed improved qualityRegular scan time with one of 4 clinical scanners plus 3 additional minutesData is presented in a Likert type scale (1=poor, 2=suboptimal, 3=average, 4=above average and 5=excellent) and imaging parameters are compared using the Wilcoxon sign rank test.

Secondary

MeasureTime frameDescription
The number of MRI scans that display severity of imaging artifactRegular scan time with one of 4 clinical scanners plus 3 additional minutesData is presented in a Likert type scale (1=poor, 2=suboptimal, 3=average, 4=above average and 5=excellent) and imaging parameters are compared using the Wilcoxon sign rank test.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026